In a welcome move, Zevra Therapeutics (ZVRA) saw its Relative Strength Rating rise from 62 to 73 on Monday. Can You Really Time The Stock Market? IBD’s proprietary rating identifies share price action with a 1 (worst) to 99 (best) score. The rating shows how a stock’s price performance over the last 52 weeks holds up against all the…
